![Michael Kyriakides](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Michael Kyriakides
Directeur/Bestuurslid bij
Purespring Therapeutics Ltd.
Profiel
Michael Kyriakides is a Board Member at Purespring Therapeutics Ltd. since 2022.
Formerly, Mr. Kyriakides was an Investment Partner at Syncona Partners LLP.
Mr. Kyriakides completed undergraduate, graduate, and doctorate degrees at Imperial College London in 2010, 2011, and 2014 respectively.
Actieve functies van Michael Kyriakides
| Bedrijven | Functie | Begin |
|---|---|---|
Purespring Therapeutics Ltd.
 Purespring Therapeutics Ltd. BiotechnologyHealth Technology Develops therapeutics for the treatment of kidney diseases | Directeur/Bestuurslid | 01-04-2022 |
Eerdere bekende functies van Michael Kyriakides
| Bedrijven | Functie | Einde |
|---|---|---|
Syncona Partners LLP
 Syncona Partners LLP Investment ManagersFinance Syncona Partners invests in companies located across the globe. The firm focuses on life science businesses and therapeutic areas.. It participates in early stage capital requirements. | Private Equity Investor | - |
Opleiding van Michael Kyriakides
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
58
Eerstegraads connecties
3
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 3 |
|---|---|
Imperial College London
 Imperial College London Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Syncona Partners LLP
Syncona Partners LLP Investment ManagersFinance Syncona Partners invests in companies located across the globe. The firm focuses on life science businesses and therapeutic areas.. It participates in early stage capital requirements. | Finance |
Purespring Therapeutics Ltd.
Purespring Therapeutics Ltd. BiotechnologyHealth Technology Develops therapeutics for the treatment of kidney diseases | Health Technology |
